statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday...

Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced a new publication validating the companys NeXT Personal test, an ultra-sensitive, tumor-informed...

Personalis Announces Publication Validating NeXT Personal Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Cathie Wood's ARK Investment bought 142K shares of Personalis today

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Directors granted, on November 15, 2023 and...

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Green Alpha Advisors LLC lowered its stake in shares of Personalis, Inc. (NASDAQ:PSNL  Free Report) by 6.2% in the fourth quarter, according to the company in its most recent Form 13F filing...

Green Alpha Advisors LLC Lowers Stake in Personalis, Inc. (NASDAQ:PSNL)

Personalis, Inc. (PSNL) Q4 2023 Earnings Call Transcript...

Personalis, Inc. (PSNL) Q4 2023 Earnings Call Transcript

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided...

Personalis Reports Fourth Quarter and Full Year 2023 Financial Results

In trading on Monday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 3.4% on the day. Components of that ETF showing particular strength include shares of Butterfly Network, up...

Video: Monday's ETF Movers: ARKG, GDX

Pathstone Family Office LLC lifted its position in shares of Personalis, Inc. (NASDAQ:PSNL  Free Report) by 149.3% during the third quarter, according to the company in its most recent filing...

Pathstone Family Office LLC Purchases 22,204 Shares of Personalis, Inc. (NASDAQ:PSNL)

Personalis, Inc. (NASDAQ:PSNL  Get Free Report) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 826,700 shares, a decrease of...

Personalis, Inc. (NASDAQ:PSNL) Short Interest Down 8.1% in January

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Volume	49,107.00
52-Wk High	$2.60
52-Wk Low	$0.8906

PSNL Personalis Inc

About

Feed

News

Sentiment

Earnings

Fundamentals